<DOC>
	<DOC>NCT00322712</DOC>
	<brief_summary>Chart Review of patients with pancreatic cancer treated with combination of irinotecan, oxaliplatin and cetuximab.</brief_summary>
	<brief_title>INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer</brief_title>
	<detailed_description>Chart Review to describe the clinical outcomes in patients pancreatic cancer treated with combination of irinotecan, oxaliplatin and cetuximab.</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Patients with unresectable/metastatic pancreatic cancer treated in the UNM Cancer Research and Treatment Center. Not specified.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>